Skye Bioscience, Inc. (SKYE) Capital expenditures 2016–2025
Skye Bioscience, Inc. (SKYE) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$6,312FY2025 · since FY2016: $11,117 → $6,312
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $6,312 | -99.6% |
| FY2024 | $1.6M | +12681.1% |
| FY2023 | $12,550 | -55.3% |
| FY2022 | $28,060 | -69.1% |
| FY2021 | $90,866 | +1156.8% |
| FY2020 | $7,230 | — |
| FY2018 | $4,385 | -77.7% |
| FY2017 | $19,654 | +76.8% |
| FY2016 | $11,117 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice